Search

everythinglearnresearchcommunity

for

Search:↓

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

Finasteride reduces alcohol withdrawal severity in male mice but increases it in female mice.

Eating disorders can cause skin problems that need treating the underlying condition for better health.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

The gene p53 is crucial for removing damaged cells to allow for healthy tissue renewal.

Reduced sexual drive may be linked to male breast cancer, while anti-estrogenic factors might lower the risk.

High-content screening is useful for finding new treatments for rare diseases and has led to FDA-approved drugs.

Regular use of sunscreen may be linked to frontal fibrosing alopecia.

The document concludes that it's important to understand the placebo effect when evaluating the effectiveness of treatments in medical trials.

Some skin disorders might be linked to H. pylori infection, but more research is needed to confirm this.

PRFM may help treat hair loss, especially in mild cases.

The document concludes that certain mutations may contribute to the inflammation in hidradenitis suppurativa and suggests that targeting TNFα could be a treatment strategy.

Blocking SCD1 in the skin with XEN103 shrinks sebaceous glands in mice.

Most pregnant women experience skin changes like darkening and itching, while serious skin conditions are rare but need early treatment.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Platelet-Rich Plasma (PRP) is a low-risk treatment for Androgenic Alopecia (AGA) that generally improves hair count or density, but more research is needed for optimization.

Methotrexate for rheumatoid arthritis often causes side effects like diarrhea, fatigue, and hair loss, especially at higher doses.

Finasteride may negatively affect male fertility.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Newborn skin is uniquely prepared to adapt to new environments compared to adult skin.

Women with polycystic ovarian syndrome are more likely to have cervical insufficiency, especially South Asian and Black women.

Finasteride for hair loss increases risk of long-lasting sexual dysfunction.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Post-finasteride patients show changes in gut bacteria, possibly causing various symptoms.

No treatment has been proven to effectively stop hair loss or regrow hair in Frontal Fibrosing Alopecia, and more research is needed.

Early balding at 40 increases prostate cancer risk.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Some children who had stem cell transplants developed permanent hair loss, especially when treated with a drug called busulphan.